List of Contents

Shock Wave Therapy Market Size, Share, and Trends 2024 to 2034

The global shock wave therapy market size accounted for USD 2.09 billion in 2024, grew to USD 2.32 billion in 2025 and is predicted to surpass around USD 5.93 billion by 2034, representing a healthy CAGR of 11% between 2024 and 2034. The North America shock wave therapy market size is calculated at USD 961.40 million in 2024 and is expected to grow at a fastest CAGR of 11.18% during the forecast year.

  • Last Updated : December 2024
  • Report Code : 1861
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Shock Wave Therapy Market 

5.1. COVID-19 Landscape: Shock Wave Therapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Shock Wave Therapy Market, By Technique

8.1. Shock Wave Therapy Market, by Technique, 2024-2034

8.1.1. Radial Shock Waves

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Electromagnetic Shock Waves

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Electrohydraulic Shock Waves

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Piezoelectric Shock Waves

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Shock Wave Therapy Market, By Product

9.1. Shock Wave Therapy Market, by Product, 2024-2034

9.1.1. Fixed Shockwave Therapy Devices

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Mobile Shockwave Therapy Devices

9.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Shock Wave Therapy Market, By Diseases 

10.1. Shock Wave Therapy Market, by Diseases, 2024-2034

10.1.1. Medial Tibial Stress Syndrome

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Upper & Lower Extremity Tendinopathies

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Long Bone Fracture

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Plantar Fasciopathy

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. Avasive Necrosis

10.1.5.1. Market Revenue and Forecast (2021-2034)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Shock Wave Therapy Market, By Application

11.1. Shock Wave Therapy Market, by Application, 2024-2034

11.1.1. Urology

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Cardiology

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Orthopedic

11.1.3.1. Market Revenue and Forecast (2021-2034)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Shock Wave Therapy Market, By End User

12.1. Shock Wave Therapy Market, by End User, 2024-2034

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2021-2034)

12.1.2. Clinics

12.1.2.1. Market Revenue and Forecast (2021-2034)

12.1.3. Diagnostic Laboratories

12.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 13. Global Shock Wave Therapy Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Technique (2021-2034)

13.1.2. Market Revenue and Forecast, by Product (2021-2034)

13.1.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.1.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.5. Market Revenue and Forecast, by End User (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Technique (2021-2034)

13.1.6.2. Market Revenue and Forecast, by Product (2021-2034)

13.1.6.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.1.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.7. Market Revenue and Forecast, by End User (2021-2034) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Technique (2021-2034)

13.1.8.2. Market Revenue and Forecast, by Product (2021-2034)

13.1.8.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.1.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.1.8.5. Market Revenue and Forecast, by End User (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Technique (2021-2034)

13.2.2. Market Revenue and Forecast, by Product (2021-2034)

13.2.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.2.4. Market Revenue and Forecast, by Application (2021-2034) 

13.2.5. Market Revenue and Forecast, by End User (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Technique (2021-2034)

13.2.6.2. Market Revenue and Forecast, by Product (2021-2034)

13.2.6.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.2.7. Market Revenue and Forecast, by Application (2021-2034) 

13.2.8. Market Revenue and Forecast, by End User (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Technique (2021-2034)

13.2.9.2. Market Revenue and Forecast, by Product (2021-2034)

13.2.9.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.2.10. Market Revenue and Forecast, by Application (2021-2034)

13.2.11. Market Revenue and Forecast, by End User (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Technique (2021-2034)

13.2.12.2. Market Revenue and Forecast, by Product (2021-2034)

13.2.12.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.2.12.4. Market Revenue and Forecast, by Application (2021-2034)

13.2.13. Market Revenue and Forecast, by End User (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Technique (2021-2034)

13.2.14.2. Market Revenue and Forecast, by Product (2021-2034)

13.2.14.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.2.14.4. Market Revenue and Forecast, by Application (2021-2034)

13.2.15. Market Revenue and Forecast, by End User (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Technique (2021-2034)

13.3.2. Market Revenue and Forecast, by Product (2021-2034)

13.3.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.3.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.5. Market Revenue and Forecast, by End User (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Technique (2021-2034)

13.3.6.2. Market Revenue and Forecast, by Product (2021-2034)

13.3.6.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.3.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.7. Market Revenue and Forecast, by End User (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Technique (2021-2034)

13.3.8.2. Market Revenue and Forecast, by Product (2021-2034)

13.3.8.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.3.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.9. Market Revenue and Forecast, by End User (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Technique (2021-2034)

13.3.10.2. Market Revenue and Forecast, by Product (2021-2034)

13.3.10.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.3.10.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.10.5. Market Revenue and Forecast, by End User (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Technique (2021-2034)

13.3.11.2. Market Revenue and Forecast, by Product (2021-2034)

13.3.11.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.3.11.4. Market Revenue and Forecast, by Application (2021-2034)

13.3.11.5. Market Revenue and Forecast, by End User (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Technique (2021-2034)

13.4.2. Market Revenue and Forecast, by Product (2021-2034)

13.4.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.4.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.5. Market Revenue and Forecast, by End User (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Technique (2021-2034)

13.4.6.2. Market Revenue and Forecast, by Product (2021-2034)

13.4.6.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.4.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.7. Market Revenue and Forecast, by End User (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Technique (2021-2034)

13.4.8.2. Market Revenue and Forecast, by Product (2021-2034)

13.4.8.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.4.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.9. Market Revenue and Forecast, by End User (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Technique (2021-2034)

13.4.10.2. Market Revenue and Forecast, by Product (2021-2034)

13.4.10.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.4.10.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.10.5. Market Revenue and Forecast, by End User (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Technique (2021-2034)

13.4.11.2. Market Revenue and Forecast, by Product (2021-2034)

13.4.11.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.4.11.4. Market Revenue and Forecast, by Application (2021-2034)

13.4.11.5. Market Revenue and Forecast, by End User (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Technique (2021-2034)

13.5.2. Market Revenue and Forecast, by Product (2021-2034)

13.5.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.5.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.5. Market Revenue and Forecast, by End User (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Technique (2021-2034)

13.5.6.2. Market Revenue and Forecast, by Product (2021-2034)

13.5.6.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.5.6.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.7. Market Revenue and Forecast, by End User (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Technique (2021-2034)

13.5.8.2. Market Revenue and Forecast, by Product (2021-2034)

13.5.8.3. Market Revenue and Forecast, by Diseases (2021-2034)

13.5.8.4. Market Revenue and Forecast, by Application (2021-2034)

13.5.8.5. Market Revenue and Forecast, by End User (2021-2034)

Chapter 14. Company Profiles

14.1. Dornier MedTech GmbH

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Zimmer MedizinSysteme GmbH

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Medtrue Enterprise Co. Ltd.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. MS Electro Medical Systems S.A.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. BTL Corporate

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Lumenis Ltd

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Edaptms TMS

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Boston Scientific Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. C.R. Bard Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Cook Group Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global shock wave therapy market size was accounted at USD 2.09 billion in 2024 and it is expected to reach around USD 5.93 billion by 2034.

The global shock wave therapy market is poised to grow at a CAGR of 11% from 2024 to 2034.

The major players operating in the shock wave therapy market are Dornier MedTech GmbH, Zimmer MedizinSysteme GmbH, Medtrue Enterprise Co. Ltd., MS Electro Medical Systems S.A., BTL Corporate, Lumenis Ltd., Edaptms TMS, Boston Scientific Corporation, C.R. Bard Inc., Cook Group Inc., Olympus Corporation

Orthopedic surgeries are carried out easily with accuracy with the help of these shockwave therapies. The pain of the individual is managed quickly with faster healing processes. These multiple benefits prove to be the driving factors for the market during the forecast period.

North America region will lead the global shock wave therapy market during the forecast period 2024 to 2034.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us